Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
Sign Up to like & getrecommendations! Published in 2024 at "Dermatology and Therapy"
DOI: 10.1007/s13555-024-01152-w
Abstract: Psoriasis is now considered a systemic disease, and several comorbidities have been described such as cardiovascular diseases, neurologic and psychiatric disorders, chronic inflammatory bowel disease, psoriatic arthritis, etc. Regarding cardiovascular comorbidities, major adverse cardiovascular events… read more here.
Keywords: cardiovascular comorbidities; psoriasis molecular; molecular target; target therapies ... See more keywords